1
TÍTULO: Non-HDL-cholesterol in dyslipidemia: Review of the state-of-the-art literature and outlook  Full Text
AUTORES: Raja, Vikrama; Aguiar, Carlos; Alsayed, Nasreen; Chibber, Yogeyaa S.; Elbadawi, Hussein; Ezhov, Marat; Hermans, Michel P.; Pandey, Ramesh Chandra; Ray, Kausik K.; Tokgozoglu, Lale; Zambon, Alberto; Berrou, Jean Pascal; Farnier, Michel;
PUBLICAÇÃO: 2023, FONTE: ATHEROSCLEROSIS, VOLUME: 383
INDEXADO EM: Scopus WOS
2
TÍTULO: Practical guidance for combination lipid-modifying therapy in high- and very-high-risk patients: A statement from a European Atherosclerosis Society Task Force  Full Text
AUTORES: Averna, M; Banach, M; Bruckert, E; Drexel, H; Farnier, M; Gaita, D; Magni, P; Marz, W; Masana, L; Silva, AME; Reiner, Z; Ros, E; Vrablik, M; Zambon, A; Zamorano, JL; Stock, JK; Tokgozoglu, LS; Catapano, AL;
PUBLICAÇÃO: 2021, FONTE: ATHEROSCLEROSIS, VOLUME: 325
INDEXADO EM: Scopus WOS
3
TÍTULO: Current practice in identifying and treating cardiovascular risk, with a focus on residual risk associated with atherogenic dyslipidaemia
AUTORES: Roberto Ferrari; Carlos Aguiar; Eduardo Alegria; Riccardo C Bonadonna; Francesco Cosentino; Moses Elisaf; Michel Farnier; Jean Ferrieres; Pasquale Perrone Filardi; Nicolae Hancu; Meral Kayikcioglu; Alberto Mello e Silva; Jesus Millan; Zeljko Reiner; Lale Tokgozoglu; Paul Valensi; Margus Viigimaa; Michal Vrablik; Alberto Zambon; Jose L Luis Zamorano; Alberico L Catapano; ...Mais
PUBLICAÇÃO: 2016, FONTE: EUROPEAN HEART JOURNAL SUPPLEMENTS, VOLUME: 18, NÚMERO: C
INDEXADO EM: Scopus WOS
4
TÍTULO: A review of the evidence on reducing macrovascular risk in patients with atherogenic dyslipidaemia: A report from an expert consensus meeting on the role of fenofibrate-statin combination therapy  Full Text
AUTORES: Carlos Aguiar; Eduardo Alegria; Riccardo C Bonadonna; Alberico L Catapano; Francesco Cosentino; Moses Elisaf; Michel Farnier; Jean Ferrieres; Pasquale Perrone Filardi; Nicolae Hancu; Meral Kayikcioglu; Alberto M E Mello e Silva; Jesus Millan; Zeljko Reiner; Lale Tokgozoglu; Paul Valensi; Margus Viigimaa; Michal Vrablik; Alberto Zambon; Jose L Luis Zamorano; Roberto Ferrari; ...Mais
PUBLICAÇÃO: 2015, FONTE: ATHEROSCLEROSIS SUPPLEMENTS, VOLUME: 19
INDEXADO EM: Scopus WOS CrossRef